Iridian Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Iridian Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-30,595	Closed	-$144K	–	106
2015 Q3	$144K	Buy	30,595 +3,575	+13%	+$23.1K	﹤0.01%	82
2015 Q2	$193K	Buy	27,020 +9,680	+56%	+$72.8K	﹤0.01%	86
2015 Q1	$147K	Buy	17,340 +2,490	+17%	+$21.2K	﹤0.01%	71
2014 Q4	$138K	Sell	14,850 -6,390	-30%	-$55.5K	﹤0.01%	71
2014 Q3	$177K	Buy	21,240 +7,770	+58%	+$72K	﹤0.01%	99
2014 Q2	$156K	Sell	13,470 -510	-4%	-$5.23K	﹤0.01%	106
2014 Q1	$177K	Sell	13,980 -23,800	-63%	-$308K	﹤0.01%	121
2013 Q4	$409K	Buy	+37,780	New	+$439K	﹤0.01%	98

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Iridian Asset Management's DSCI Position: Q4 2015 in Review

Iridian Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2015, closing a stake of 30,595 shares — an estimated $144K sold.

Iridian Asset Management first reported a position in DSCI in Q4 2013 and held it in 8 quarters. The position peaked at $409K in Q4 2013. 59 funds tracked by Wall St. Rank hold DSCI as of Q4 2015.

Iridian Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2015 after selling out during the quarter.
Iridian Asset Management sold 30,595 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2015, an estimated $144K.
Iridian Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2013 and held it in 8 quarters.
Iridian Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $409K in Q4 2013.
59 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2015.

Based on Iridian Asset Management's 13F filing for Q4 2015, filed 5 Feb 2016.